NRC — National Research Income Statement
0.000.00%
Last trade - 00:00
- $522.78m
- $564.52m
- $148.58m
- 95
- 40
- 28
- 53
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 128 | 133 | 148 | 152 | 149 |
Cost of Revenue | |||||
Gross Profit | 81.5 | 84.1 | 95.6 | 94.5 | 92.6 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 84.9 | 90.6 | 97.7 | 105 | 109 |
Operating Profit | 43 | 42.7 | 50.3 | 46.5 | 40 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 40.5 | 41.5 | 48.6 | 42.8 | 40 |
Provision for Income Taxes | |||||
Net Income After Taxes | 32.4 | 37.3 | 37.5 | 31.8 | 31 |
Net Income Before Extraordinary Items | |||||
Net Income | 32.4 | 37.3 | 37.5 | 31.8 | 31 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 32.3 | 37.2 | 37.4 | 31.8 | 31 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.26 | 1.43 | 1.47 | 1.68 | 1.26 |
Dividends per Share | |||||
Special Dividends per Share |